Defence Therapeutics Inc.
DTC
Peringkat dalam Saham
#29780
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Harga Saham
$0.24953854
Terakhir disinkronkan: 2026-10-16
Kapitalisasi Pasar
$18.91M
Perubahan (1 hari)
-5.56%
Perubahan (1 tahun)
-53.23%
Negara
CA
Perdagangan Defence Therapeutics Inc. (DTC)
Kategori
Healthcare
Kapitalisasi pasar dari Defence Therapeutics Inc.(DTC)
Kapitalisasi Pasar: $18.91M
Per October 2026, Defence Therapeutics Inc. memiliki kapitalisasi pasar sebesar $18.91M. Ini menjadikan Defence Therapeutics Inc. sebagai perusahaan 29780th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Defence Therapeutics Inc. dari 2021 hingga 2026
DTC dibandingkan dengan 5 teratas stocks paling populer
